Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle

NCT02817464 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Pregnancy
Contraception

Interventions

DRUG: TV-46046 - 400 mg/mL
DRUG: TV-46046 - 200 mg/mL

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.

Collaborators

[object Object]